{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:46:54Z","timestamp":1794458814169,"version":"4.9.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05598-7","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T04:59:44Z","timestamp":1765861184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Alterations of Gut Microbiota and Microbial Metabolites in Parkinson\u2019s Disease: A Systematic Review"],"prefix":"10.1007","volume":"63","author":[{"given":"Samin","family":"Davoody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Heidari-Foroozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Mofidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Taremi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Taherkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Hojjati","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Zangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Mohamadkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"1","key":"5598_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz A, Carcaillon L, Kab S, Moisan F (2016) Epidemiology of Parkinson\u2019s disease. Rev Neurol (Paris) 172(1):14\u201326","journal-title":"Rev Neurol (Paris)"},{"key":"5598_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08403-4","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi R, Bordbar S, Azad G, Davoody S, Mahmoudi M, Esmaeilpour K (2025) Beyond neuroinflammation: microglia at the crossroads of amyloid, tau, and neurodegeneration in Alzheimer\u2019s disease. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08403-4","journal-title":"Neurol Sci"},{"issue":"2","key":"5598_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E (2018) Bile acids in glucose metabolism in health and disease. J Exp Med 215(2):383\u2013396","journal-title":"J Exp Med"},{"issue":"1","key":"5598_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28(1):24\u201330","journal-title":"Mov Disord"},{"issue":"2","key":"5598_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000502292","volume":"19","author":"N Nag","year":"2019","unstructured":"Nag N, Jelinek GA (2019) A narrative review of lifestyle factors associated with Parkinson\u2019s disease risk and progression. Neurodegener Dis 19(2):51\u201359","journal-title":"Neurodegener Dis"},{"key":"5598_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00218","author":"N Ball","year":"2019","unstructured":"Ball N, Teo W-P, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Front Neurol"},{"key":"5598_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176016","volume":"14","author":"M Bronzini","year":"2023","unstructured":"Bronzini M, Maglione A, Rosso R, Matta M, Masuzzo F, Rolla S et al (2023) Feeding the gut microbiome: impact on multiple sclerosis. Front Immunol 14:1176016","journal-title":"Front Immunol"},{"issue":"5","key":"5598_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WMd Vos","year":"2022","unstructured":"Vos WMd, Tilg H, Hul MV, Cani PD (2022) Gut microbiome and health: mechanistic insights. Gut 71(5):1020\u20131032","journal-title":"Gut"},{"key":"5598_CR9","doi-asserted-by":"publisher","unstructured":"Hooks KB, O'Malley MA (2017) Dysbiosis and its discontents. mBio 8(5):e01492\u201317. https:\/\/doi.org\/10.1128\/mBio.01492-17","DOI":"10.1128\/mBio.01492-17"},{"key":"5598_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.813204","volume":"9","author":"L Mitrea","year":"2022","unstructured":"Mitrea L, Nemes SA, Szabo K, Teleky BE, Vodnar DC (2022) Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front Med (Lausanne) 9:813204","journal-title":"Front Med (Lausanne)"},{"issue":"26S","key":"5598_CR11","first-page":"756","volume":"14","author":"ME Jan","year":"2025","unstructured":"Jan ME, Datta O, Upadhayay D, Sagar SD, Kuumar P, Fairoos AM et al (2025) Evaluation of cerebrospinal fluid and plasma biomarkers for disease progression in Parkinson\u2019s disease using a public dataset. Journal of Neonatal Surgery 14(26S):756\u2013760","journal-title":"Journal of Neonatal Surgery"},{"key":"5598_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107032","volume":"214","author":"S Davoody","year":"2025","unstructured":"Davoody S, Halimi H, Zali A, Houri H, Brand S (2025) Double-edged sword effect of Sutterella in neurological disorders: implications for the gut-brain axis and neuroimmune interactions. Neurobiol Dis 214:107032","journal-title":"Neurobiol Dis"},{"key":"5598_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2025.110143","author":"S Davoody","year":"2025","unstructured":"Davoody S, Mansouri M, Houri H (2025) Potential of Limosilactobacillus reuteri in modulating neuroplasticity and ameliorating behavioral deficits in a maternal separation rat model of autism. J Nutr Biochem. https:\/\/doi.org\/10.1016\/j.jnutbio.2025.110143","journal-title":"J Nutr Biochem"},{"issue":"1","key":"5598_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/07853890.2021.1890330","volume":"53","author":"E Menozzi","year":"2021","unstructured":"Menozzi E, Macnaughtan J, Schapira AHV (2021) The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 53(1):611\u2013625","journal-title":"Ann Med"},{"issue":"2","key":"5598_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","volume":"42","author":"N Dogra","year":"2022","unstructured":"Dogra N, Mani RJ, Katare DP (2022) The gut-brain axis: two ways signaling in Parkinson\u2019s disease. Cell Mol Neurobiol 42(2):315\u2013332","journal-title":"Cell Mol Neurobiol"},{"key":"5598_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5598_CR17","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/mds.28246","volume":"35","author":"SJ Chen","year":"2020","unstructured":"Chen SJ, Kuo CH, Kuo HC, Chen CC, Wu WK, Liou JM et al (2020) The gut metabolite trimethylamine N-oxide is associated with Parkinson\u2019s disease severity and progression. Mov Disord 35(11):2115\u20136","journal-title":"Mov Disord"},{"key":"5598_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fnins.2019.01365","volume":"13","author":"H Kaur","year":"2019","unstructured":"Kaur H, Bose C, Mande SS (2019) Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis. Front Neurosci 13:1365","journal-title":"Front Neurosci"},{"key":"5598_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101347","volume":"69","author":"S-Y Zheng","year":"2021","unstructured":"Zheng S-Y, Li H-X, Xu R-C, Miao W-T, Dai M-Y, Ding S-T et al (2021) Potential roles of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev 69:101347","journal-title":"Ageing Res Rev"},{"issue":"s2","key":"5598_CR20","doi-asserted-by":"publisher","first-page":"S359","DOI":"10.3233\/JPD-191780","volume":"9","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, El Aidy S (2019) Bacterial metabolites mirror altered gut microbiota composition in patients with Parkinson\u2019s disease. J Parkinsons Dis 9(s2):S359-s70","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"5598_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group* P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"key":"5598_CR22","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford"},{"key":"5598_CR23","first-page":"15","volume":"2013","author":"H Sch\u00fcnemann","year":"2013","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A (2013) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013:15","journal-title":"Updated October"},{"key":"5598_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P et al (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44:691\u2013707","journal-title":"EBioMedicine"},{"issue":"10","key":"5598_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB et al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u201360","journal-title":"Mov Disord"},{"issue":"3","key":"5598_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S et al (2019) Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord 34(3):396\u2013405","journal-title":"Mov Disord"},{"issue":"7","key":"5598_CR27","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N et al (2020) Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord 35(7):1208\u201317","journal-title":"Mov Disord"},{"key":"5598_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.871710","volume":"12","author":"SC Fu","year":"2022","unstructured":"Fu SC, Shih LC, Wu PH, Hsieh YC, Lee CH, Lin SH et al (2022) Exploring the causal effect of constipation on Parkinson\u2019s disease through mediation analysis of microbial data. Front Cell Infect Microbiol 12:871710","journal-title":"Front Cell Infect Microbiol"},{"key":"5598_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00839","volume":"13","author":"AM Gorecki","year":"2019","unstructured":"Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G et al (2019) Altered gut microbiome in Parkinson\u2019s disease and the influence of lipopolysaccharide in a human \u03b1-synuclein over-expressing mouse model. Front Neurosci 13:839","journal-title":"Front Neurosci"},{"issue":"11","key":"5598_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K et al (2015) Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease. PLoS One 10(11):e0142164","journal-title":"PLoS One"},{"issue":"5","key":"5598_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","volume":"41","author":"S Kumari","year":"2020","unstructured":"Kumari S, Goyal V, Kumaran SS, Dwivedi SN, Srivastava A, Jagannathan NR (2020) Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson\u2019s disease and healthy controls. Neurol Sci 41(5):1201\u20131210","journal-title":"Neurol Sci"},{"key":"5598_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010029","author":"P Li","year":"2021","unstructured":"Li P, Killinger BA, Ensink E, Beddows I, Yilmaz A, Lubben N et al (2021) Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson\u2019s disease. Metabolites. https:\/\/doi.org\/10.3390\/metabo11010029","journal-title":"Metabolites"},{"issue":"11","key":"5598_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y et al (2017) Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 60(11):1223\u20131233","journal-title":"Sci China Life Sci"},{"issue":"1","key":"5598_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-215411","volume":"87","author":"J Ning","year":"2022","unstructured":"Ning J, Huang SY, Chen SD, Zhang YR, Huang YY, Yu JT (2022) Investigating casual associations among gut microbiota, metabolites, and neurodegenerative diseases: a mendelian randomization study. J Alzheimers Dis 87(1):211\u2013222","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"5598_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB et al (2017) Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med 162(6):734\u2013737","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"5598_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF et al (2021) Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol 89(3):546\u201359","journal-title":"Ann Neurol"},{"key":"5598_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105780","volume":"170","author":"RM Voigt","year":"2022","unstructured":"Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG et al (2022) Gut microbial metabolites in Parkinson\u2019s disease: association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis 170:105780","journal-title":"Neurobiol Dis"},{"key":"5598_CR38","first-page":"2447","volume":"27","author":"R Pathak","year":"2024","unstructured":"Pathak R, Sharma S, Bhandari M, Nogai L, Mishra R, Saxena A et al (2024) Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: causes, consequences and interventions. JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA 27:2447\u20132461","journal-title":"JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA"},{"key":"5598_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2020.111090","volume":"83","author":"SJ Chung","year":"2021","unstructured":"Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH et al (2021) Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson\u2019s disease. Nutrition 83:111090","journal-title":"Nutrition"},{"issue":"1","key":"5598_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A, Pandey U, Wicke T, Sixel-D\u00f6ring F, Janzen A, Sittig-Wiegand E et al (2018) The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88\u201398","journal-title":"Mov Disord"},{"issue":"5","key":"5598_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u201349","journal-title":"Mov Disord"},{"key":"5598_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner F, Kunstner A, Muller SH, Kunzel S, Zeuner KE, Margraf NG et al (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u20135","journal-title":"Brain Res"},{"key":"5598_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.756951","volume":"15","author":"JE Kenna","year":"2021","unstructured":"Kenna JE, Chua EG, Bakeberg M, Tay A, McGregor S, Gorecki A et al (2021) Changes in the gut microbiome and predicted functional metabolic effects in an Australian Parkinson\u2019s Disease cohort. Front Neurosci 15:756951","journal-title":"Front Neurosci"},{"key":"5598_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10020302","author":"CH Kim","year":"2022","unstructured":"Kim CH, Jung J, Lee YU, Kim KH, Kang S, Kang GH et al (2022) Comparison of metabolites and gut microbes between patients with Parkinson\u2019s disease and healthy individuals-a pilot clinical observational study (STROBE compliant). Healthcare. https:\/\/doi.org\/10.3390\/healthcare10020302","journal-title":"Healthcare"},{"key":"5598_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134297","volume":"707","author":"F Li","year":"2019","unstructured":"Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J (2019) Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson\u2019s disease. Neurosci Lett 707:134297","journal-title":"Neurosci Lett"},{"key":"5598_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","volume":"53","author":"A Lin","year":"2018","unstructured":"Lin A, Zheng W, He Y, Tang W, Wei X, He R et al (2018) Gut microbiota in patients with Parkinson\u2019s disease in southern China. Parkinsonism Relat Disord 53:82\u20138","journal-title":"Parkinsonism Relat Disord"},{"key":"5598_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB et al (2019) Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients. Parkinsonism Relat Disord 65:124\u201330","journal-title":"Parkinsonism Relat Disord"},{"key":"5598_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N et al (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"5598_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00137","volume":"11","author":"T Ren","year":"2020","unstructured":"Ren T, Gao Y, Qiu Y, Jiang S, Zhang Q, Zhang J et al (2020) Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s disease. Front Neurol 11:137","journal-title":"Front Neurol"},{"issue":"1","key":"5598_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00775-7","volume":"18","author":"F Baldini","year":"2020","unstructured":"Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L et al (2020) Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 18(1):62","journal-title":"BMC Biol"},{"issue":"1","key":"5598_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16(1):129","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5598_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E (2015) <article-title update=\"added\">Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u20138","journal-title":"Mov Disord"},{"issue":"1","key":"5598_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu G, Jiang Z, Pu Y, Chen S, Wang T, Wang Y et al (2022) Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol 22(1):13","journal-title":"BMC Neurol"},{"issue":"4","key":"5598_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.parkreldis.2015.02.004","volume":"21","author":"E Cassani","year":"2015","unstructured":"Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E (2015) <article-title update=\"added\">Increased urinary indoxyl sulfate (indican): New insights into gut dysbiosis in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(4):389\u201393","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"5598_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00300-3","volume":"8","author":"PAB Pereira","year":"2022","unstructured":"Pereira PAB, Trivedi DK, Silverman J, Duru IC, Paulin L, Auvinen P (2022) Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):39","journal-title":"NPJ Parkinsons Dis"},{"key":"5598_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00561-20","author":"S Vascellari","year":"2020","unstructured":"Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R, Uva P et al (2020) Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems. https:\/\/doi.org\/10.1128\/mSystems.00561-20","journal-title":"mSystems"},{"issue":"1","key":"5598_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00312-z","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, He X, Qian Y, Xu S, Mo C, Yan Z (2022) Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):48","journal-title":"NPJ Parkinsons Dis"},{"key":"5598_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109436","volume":"134","author":"Y Hasuike","year":"2020","unstructured":"Hasuike Y, Endo T, Koroyasu M, Matsui M, Mori C, Yamadera M (2020) Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson\u2019s disease. Med Hypotheses 134:109436","journal-title":"Med Hypotheses"},{"key":"5598_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J (2016) <article-title update=\"added\">Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"5598_CR60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn TB (2020) Plasma short-chain fatty acids in patients with Parkinson\u2019s disease. Mov Disord 35(6):1021\u20131027","journal-title":"Mov Disord"},{"issue":"8","key":"5598_CR61","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM et al (2022) Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98(8):e848\u2013e858","journal-title":"Neurology"},{"issue":"3","key":"5598_CR62","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3233\/JPD-212604","volume":"11","author":"X He","year":"2021","unstructured":"He X, Qian Y, Xu S, Zhang Y, Mo C, Guo W et al (2021) Plasma short-chain fatty acids differences in multiple system atrophy from Parkinson\u2019s disease. J Parkinsons Dis 11(3):1167\u201376","journal-title":"J Parkinsons Dis"},{"issue":"30","key":"5598_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043542","volume":"104","author":"OP Ugwu","year":"2025","unstructured":"Ugwu OP, Okon MB, Alum EU, Ugwu CN, Anyanwu EG, Mariam B et al (2025) Unveiling the therapeutic potential of the gut microbiota-brain axis: novel insights and clinical applications in neurological disorders. Medicine Baltimore 104(30):e43542","journal-title":"Medicine Baltimore"},{"issue":"8","key":"5598_CR64","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian Y, Yang X, Xu S, Huang P, Li B, Du J et al (2020) Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 143(8):2474\u20132489","journal-title":"Brain"},{"issue":"Suppl 1","key":"5598_CR65","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1017\/S031716710000319X","volume":"30","author":"Z Huang","year":"2003","unstructured":"Huang Z, de la Fuente-Fernandez R, Stoessl AJ (2003) Etiology of Parkinson\u2019s disease. Can J Neurol Sci 30(Suppl 1):S10\u2013S18","journal-title":"Can J Neurol Sci"},{"issue":"16","key":"5598_CR66","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"GA Weiss","year":"2017","unstructured":"Weiss GA, Hennet T (2017) Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci 74(16):2959\u20132977","journal-title":"Cell Mol Life Sci"},{"key":"5598_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch A, Kantsjo JB, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11:604179","journal-title":"Front Immunol"},{"issue":"1","key":"5598_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00775-7","volume":"18","author":"F Baldini","year":"2020","unstructured":"Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L et al (2020) Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 18(1):62","journal-title":"BMC Biol"},{"issue":"1","key":"5598_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG et al (2022) Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun 13(1):6958","journal-title":"Nat Commun"},{"key":"5598_CR70","doi-asserted-by":"crossref","unstructured":"Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, et al (20190 Altered gut microbiome in Parkinson\u2019s disease and the influence of lipopolysaccharide in a human alpha-synuclein over-expressing mouse model. Front Neurosci. 13:839.","DOI":"10.3389\/fnins.2019.00839"},{"issue":"1","key":"5598_CR71","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","volume":"29","author":"Z Li","year":"2023","unstructured":"Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y et al (2023) Gut bacterial profiles in Parkinson\u2019s disease: a systematic review. CNS Neurosci Ther 29(1):140\u201357","journal-title":"CNS Neurosci Ther"},{"issue":"s2","key":"5598_CR72","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-191711","volume":"9","author":"JM Boertien","year":"2019","unstructured":"Boertien JM, Pereira PAB, Aho VTE, Scheperjans F (2019) Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review. J Parkinsons Dis 9(s2):S297\u2013S312","journal-title":"J Parkinsons Dis"},{"key":"5598_CR73","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis M, Niccolini F (2015) Serotonin in Parkinson\u2019s disease. Behav Brain Res 277:136\u2013145","journal-title":"Behav Brain Res"},{"issue":"9","key":"5598_CR74","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E et al (2013) The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord 28(9):1241\u20139","journal-title":"Mov Disord"},{"issue":"8","key":"5598_CR75","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"LP Kelly","year":"2014","unstructured":"Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA et al (2014) Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov Disord 29(8):999\u20131009","journal-title":"Mov Disord"},{"issue":"5","key":"5598_CR76","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","volume":"22","author":"G Dutta","year":"2008","unstructured":"Dutta G, Zhang P, Liu B (2008) The lipopolysaccharide Parkinson\u2019s disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol 22(5):453\u2013464","journal-title":"Fundam Clin Pharmacol"},{"key":"5598_CR77","first-page":"4328","volume":"6","author":"H Sharma","year":"2024","unstructured":"Sharma H, Chandra P, Pathak R, Bhandari M, Sharma A (2024) Advancements in the therapeutic approaches to treat neurological disorders. Cah Geol 6:4328\u20134389","journal-title":"Cah Geol"},{"key":"5598_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2017","unstructured":"Yang X, Qian Y, Xu S, Song Y, Xiao Q (2017) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease. Front Aging Neurosci 9:441","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"5598_CR79","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 110(5):517\u2013536","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"5598_CR80","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"6","key":"5598_CR81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"5598_CR82","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5598_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.871710","author":"S-C Fu","year":"2022","unstructured":"Fu S-C, Shih L-C, Wu P-H, Hsieh Y-C, Lee C-H, Lin S-H et al (2022) Exploring the causal effect of constipation on Parkinson\u2019s disease through mediation analysis of microbial data. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.871710","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"5598_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 6(12):e28032","journal-title":"PLoS One"},{"key":"5598_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H et al (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 50:42\u20138","journal-title":"Neurobiol Dis"},{"key":"5598_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103092","volume":"71","author":"B Kalyanaraman","year":"2024","unstructured":"Kalyanaraman B, Cheng G, Hardy M (2024) Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications. Redox Biol 71:103092","journal-title":"Redox Biol"},{"key":"5598_CR87","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease. Front Neurosci 13:369","journal-title":"Front Neurosci"},{"issue":"5","key":"5598_CR88","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1007\/s12035-025-04726-7","volume":"62","author":"Y Qu","year":"2025","unstructured":"Qu Y, An K, Wang D, Yu H, Li J, Min Z et al (2025) Short-chain fatty acid aggregates alpha-synuclein accumulation and neuroinflammation via GPR43-NLRP3 signaling pathway in a model Parkinson\u2019s disease. Mol Neurobiol 62(5):6612\u20136625","journal-title":"Mol Neurobiol"},{"issue":"2","key":"5598_CR89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbapap.2004.10.008","volume":"1703","author":"CB Glaser","year":"2005","unstructured":"Glaser CB, Yamin G, Uversky VN, Fink AL (2005) Methionine oxidation, alpha-synuclein and Parkinson\u2019s disease. Biochim Biophys Acta 1703(2):157\u2013169","journal-title":"Biochim Biophys Acta"},{"key":"5598_CR90","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","volume":"112","author":"ND Nuzum","year":"2020","unstructured":"Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H (2020) Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: a systematic review. Neurosci Biobehav Rev 112:227\u2013241","journal-title":"Neurosci Biobehav Rev"},{"key":"5598_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T, Yue Y, He T, Huang C, Qu B, Lv W et al (2021) The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci 13:636545","journal-title":"Front Aging Neurosci"},{"key":"5598_CR92","doi-asserted-by":"crossref","unstructured":"Moeenrad A, Alizadeh Jouimandi F, Kamalahmadi N, Ghofrani Ivari A, Davoody S, Mohaddes Ardabili H, et al (2023) \u201cArt and Psyche Festival\u201d: utilizing the power of art against the stigma around mental illness. Frontiers in Psychiatry. 13:127316","DOI":"10.3389\/fpsyt.2022.1027316"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05598-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:03:12Z","timestamp":1765904592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05598-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5598"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05598-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"299"}}